The Association of Fenofibrate with Kidney Tubular Injury in a Subgroup of Participants in the ACCORD Trial

Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1521-1523. doi: 10.2215/CJN.00370119. Epub 2019 Aug 13.

Authors

Kinsuk Chauhan¹, Girish N Nadkarni¹, Neha Debnath¹, Lili Chan¹, Aparna Saha¹, Amit X Garg^{2

3}, Chirag R Parikh⁴, Steven G Coca¹

Affiliations

¹ Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
² Institute for Clinical Evaluative Sciences, Toronto, Canada.
³ Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; and.
⁴ Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.

No abstract available

Keywords: Fenofibrate; Kidney Tubular Injury; Urine Biomarkers; hypolipidemic agents; kidney.

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Biomarkers / urine
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / urine
Female
Fenofibrate / adverse effects*
Humans
Hypolipidemic Agents / adverse effects*
Hypolipidemic Agents / therapeutic use
Kidney Diseases / chemically induced*
Kidney Diseases / urine
Kidney Tubules*
Male
Middle Aged

Substances

Biomarkers
Hypolipidemic Agents
Fenofibrate

Grants and funding